Pumping the Fluids to Save Kids' Kidneys

It is a serious problem when a child gets infected with E. coli - a bacteria that can cause kidney failure. Now, researchers have found a way to protects children's kidneys from the bacteria.

Clues to Blood Clotting

Evolutionary clues have led scientists to a discovery of how a key clotting protein assembles. This could aid in better understanding, and possibly treatments for common bleeding disorders.

Asthma Relief: All in the Head?

Could it be mind over matter? Getting relief from many asthma symptoms may be as simple as believing you are taking a treatment that will help.

Double-Whammy during Pregnancy

Being obese can make pregnancy harder than it already is. Adding type 2 diabetes to that mix makes pregnancy risky for both the mother and the baby.

Foodborne Outbreak Potentially Associated With Papaya

The FDA is warning consumers not to eat papayas from Agromod Produce, Inc., a distributor in McAllen,Texas.

Single Brain Injury May Lead to Neurodegeneration

Traumatic brain injuries are known to be a risk factor for later development of cognitive impairments. Recent findings suggest that even a singular brain injury could lead to diminished neurological capacity.

The Protective Effects of Estrogen

Estrogen has been getting a bad name lately. The female hormone drives the most common form of breast cancer, but a new study suggests it also protects women from other types of cancer.

FDA Drug Safety Communication: Letairis

The U.S. Food and Drug Administration (FDA) is removing the warning related to liver injury from the boxed warning of the Letairis ( ambrisentan ) tablet label.

FDA Drug Safety Communication: Pradaxa

The U.S. Food and Drug Administration (FDA) is alerting the public to important storage and handling requirements for Pradaxa ( dabigatran etexilate mesylate ) capsules.

FDA Drug Safety Communication: Benicar

After reviewing the results of the ROADMAP and ORIENT trials, the FDA has determined that the benefits of Benicar continue to outweigh its potential risks when used for the treatment of patients with high blood pressure according to the drug label. Benicar is not recommended as a treatment to delay or prevent protein in the urine ( microalbuminuria ) in diabetic patients. Patients should consult their healthcare professional if they have any questions or concerns about taking Benicar . Daiichi Sankyo , the makers of Benicar , have agreed to work with the FDA to perform additional ...